Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Clinical Investigation
Circulating Adiponectin Levels in Patients With Atrial Fibrillation
Masayuki ShimanoRei ShibataYukiomi TsujiHiromi KamiyaTomohiro UchikawaShuji HarataMasahiro MutoNoriyuki OuchiYasuya IndenToyoaki Murohara
Author information
JOURNAL FREE ACCESS

2008 Volume 72 Issue 7 Pages 1120-1124

Details
Abstract

Background Atrial fibrillation (AF) characterized by atrial remodeling occurs with obesity-related conditions. Adiponectin, an adipose tissue-derived hormone exerts beneficial effects on ventricular remodeling, so in the present study the potential association between circulating adiponectin levels and atrial remodeling in patients with AF was investigated. Methods and Results The levels of plasma adiponectin, serum carboxy-terminal telopeptide of collagen type I (CITP), as a collagen type I degradation marker, and serum type III procollagen-N-peptide (PIIINP), as a collagen type III synthesis marker, were measured in 304 consecutive patients (162 paroxysmal AF, 46 persistent AF, 96 paroxysmal supra-ventricular tachycardia [controls]). Plasma adiponectin levels were significantly higher in patients with persistent AF than in those with paroxysmal AF or the control patients (p<0.05). Serum CITP levels, but not serum PIIINP levels, were higher in patients with persistent AF compared with the paroxysmal AF and control patients (p<0.05). In addition, there was a positive correlation between adiponectin levels and CITP levels in patients with persistent AF (r=0.39, p<0.005). Conclusions High plasma adiponectin levels are associated with the presence of persistent AF, which is accompanied by increased CITP levels. Thus, measurement of plasma adiponectin could be useful for assessment of AF. (Circ J 2008; 72: 1120 - 1124)

Content from these authors
© 2008 THE JAPANESE CIRCULATION SOCIETY
Previous article Next article
feedback
Top